CORLANOR (ivabradine) Amgen inc Patent: 7,879,842 Expiration: Feb 22, 2026 See More … For more information on how DrugPatentWatch can […]
Drug Patent Expirations for the Week of February 22, 2026 Read Post »
BRIVIACT (brivaracetam) Ucb inc Patent: 6,911,461 Expiration: Feb 21, 2026 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of February 15, 2026 Read Post »
IZERVAY (avacincaptad pegol sodium) Astellas Patent: 9,617,546 Expiration: Feb 14, 2026 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of February 8, 2026 Read Post »
VIZIMPRO (dacomitinib) Pfizer Patent: 10,603,314 Expiration: Feb 2, 2026 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of February 1, 2026 Read Post »
VIZIMPRO (dacomitinib) Pfizer Patent: 10,603,314 Expiration: Feb 2, 2026 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of February 1, 2026 Read Post »
TAVALISSE (fostamatinib disodium) Rigel pharms Patent: 9,266,912 Expiration: Jan 19, 2026 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of January 18, 2026 Read Post »
RECORLEV (levoketoconazole) Strongbridge Patent: 11,478,471 Expiration: Jan 10, 2026 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of January 4, 2026 Read Post »
Sign in or create a free account to read this DrugPatentWatch article
